BioSig Technologies Inc.

3.44-0.0600-1.71%Vol 146.52K1Y Perf -57.48%
Jul 27th, 2021 14:50 DELAYED
BID3.42 ASK3.45
Open3.59 Previous Close3.50
Pre-Market- After-Market-
 - -%  - -
Target Price
12.50 
Analyst Rating
Strong Buy 1.00
Potential %
263.37 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/-33/87 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/-99/-44 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/-98/-31 
Income Ranking
 —    -
Market Cap110.70M 
Earnings Rating
Neutral
Price Range Ratio 52W %
9.31 
Earnings Date
5th Aug 2021

Today's Price Range

3.333.59

52W Range

2.799.77

5 Year PE Ratio Range

-3.20-3.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.31%
1 Month
-2.78%
3 Months
-7.16%
6 Months
-20.45%
1 Year
-57.48%
3 Years
-38.60%
5 Years
0.36%
10 Years
-

TickerPriceChg.Chg.%
BSGM3.44-0.0600-1.71
AAPL146.72-2.2700-1.52
GOOG2 730.44-62.4500-2.24
MSFT285.90-3.1500-1.09
XOM57.64-0.8400-1.44
WFC45.020.01000.02
JNJ172.310.44000.26
FB366.38-6.0800-1.63
GE13.110.19001.47
JPM151.38-0.2700-0.18
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.38-
Q02 2020--0.72-
Q01 2020-0.25-0.46-84.00
Q03 2019--0.25-
Q02 2019--0.38-
Q01 2018--0.22-
Q02 2017--0.30-
Q01 2017--0.35-
Earnings Per EndEstimateRevision %Trend
6/2020 QR-0.240.00-
9/2020 QR-0.230.00-
12/2020 FY-1.17-408.70Negative
12/2021 FY-0.500.00-
Next Report Date5th Aug 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume146.52K
Shares Outstanding32.18M
Trades Count843
Dollar Volume1.51M
Avg. Volume332.73K
Avg. Weekly Volume364.64K
Avg. Monthly Volume455.86K
Avg. Quarterly Volume353.55K

BioSig Technologies Inc. (NASDAQ: BSGM) stock closed at 3.5 per share at the end of the most recent trading day (a -5.41% change compared to the prior day closing price) with a volume of 1.06M shares and market capitalization of 110.70M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 53 people. BioSig Technologies Inc. CEO is Kenneth L. Londoner.

The one-year performance of BioSig Technologies Inc. stock is -57.48%, while year-to-date (YTD) performance is -10.26%. BSGM stock has a five-year performance of 0.36%. Its 52-week range is between 2.79 and 9.77, which gives BSGM stock a 52-week price range ratio of 9.31%

BioSig Technologies Inc. currently has a PE ratio of -2.20, a price-to-book (PB) ratio of 6.46, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -230.75%, a ROC of -272.00% and a ROE of -279.77%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from BioSig Technologies Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioSig Technologies Inc.’s next earnings report date is 05th Aug 2021.

The consensus rating of Wall Street analysts for BioSig Technologies Inc. is Strong Buy (1), with a target price of $12.5, which is +263.37% compared to the current price. The earnings rating for BioSig Technologies Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioSig Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioSig Technologies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.50, ATR14 : 0.32, CCI20 : -43.56, Chaikin Money Flow : -0.16, MACD : -0.04, Money Flow Index : 21.98, ROC : -8.85, RSI : 44.01, STOCH (14,3) : 24.69, STOCH RSI : 0.25, UO : 40.04, Williams %R : -75.31), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioSig Technologies Inc. in the last 12-months were: Kenneth L. Londoner (Buy at a value of $192 028), Martha Pease (Option Excercise at a value of $0), Odonnell F Jeffrey (Sold 105 000 shares of value $530 371 ), Samuel E. Navarro (Option Excercise at a value of $0), Steven Chaussy (Buy at a value of $12 079)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

BioSig Technologies Inc.

BioSig Technologies Inc is a medical technology company. The firm is commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. Its first product, PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The company's subsidiary is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.

CEO: Kenneth L. Londoner

Telephone: +1 203 409-5444

Address: 54 Wilton Road, Westport 06880, CT, US

Number of employees: 53

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

56%44%

Bearish Bullish

50%50%

News

Stocktwits